Spots Global Cancer Trial Database for thrombopoietin
Every month we try and update this database with for thrombopoietin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy | NCT00102726 | Thrombocytopaen... | SB497115 Placebo | 18 Years - | GlaxoSmithKline | |
| A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) | NCT02158936 | Thrombocytopaen... | Eltrombopag Azacitidine Placebo Placebo | 18 Years - | Novartis | |
| Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis | NCT04800458 | Thrombocytopeni... Immune Thromboc... Myelodysplasia | Blood samples | 18 Years - | University Hospital, Bordeaux | |
| Avatrombopag vs. Placebo for CIT in GI Malignancies | NCT05772546 | Gastrointestina... Gastrointestina... Chemotherapy-In... | Avatrombopag Matching Placeb... | 18 Years - | Massachusetts General Hospital | |
| rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin | NCT00038012 | Neoplasms, Gyne... | Thrombopoietin Platelet-pheres... Carboplatin | 15 Years - | M.D. Anderson Cancer Center | |
| Avatrombopag vs. Placebo for CIT in GI Malignancies | NCT05772546 | Gastrointestina... Gastrointestina... Chemotherapy-In... | Avatrombopag Matching Placeb... | 18 Years - | Massachusetts General Hospital | |
| Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis | NCT04800458 | Thrombocytopeni... Immune Thromboc... Myelodysplasia | Blood samples | 18 Years - | University Hospital, Bordeaux | |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | NCT00187109 | Germ Cell Tumor... Hepatic Cancer Neuroblastoma Osteosarcoma Rhabdomyosarcom... | Recombinant Hum... | - 21 Years | St. Jude Children's Research Hospital | |
| Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients | NCT02572596 | Multiple Myelom... | rhTPO CTX -CSF | 10 Years - 70 Years | Beijing Chao Yang Hospital | |
| A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) | NCT02158936 | Thrombocytopaen... | Eltrombopag Azacitidine Placebo Placebo | 18 Years - | Novartis | |
| Avatrombopag vs. Placebo for CIT in GI Malignancies | NCT05772546 | Gastrointestina... Gastrointestina... Chemotherapy-In... | Avatrombopag Matching Placeb... | 18 Years - | Massachusetts General Hospital | |
| Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients | NCT02572596 | Multiple Myelom... | rhTPO CTX -CSF | 10 Years - 70 Years | Beijing Chao Yang Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
